Regulation of thrombosis during Behcet disease through EBI3, IL-6 and IL-6R

被引：0

作者：

Ghozali, Nourelhouda ^{[1
]}

Belguendouz, Houda ^{[1
]}

Abdesselam, Zahira ^{[3
]}

Messaoudene, Djamel ^{[2
]}

Hadjimi, Zohra ^{[1
]}

Terahi, Malika ^{[4
]}

Kediha, Islam ^{[5
]}

Lahmar, Kariam ^{[1
]}

Pacha, Lamia Ali ^{[5
]}

Belkacem, Habiba Amroun Ait ^{[1
]}

Boukoffa, Chafia Touil ^{[1
]}

机构：

[1] USTHB, LBCM, FSB, Algiers, Algeria

[2] UMBB, FS, La Valorizat & Conservat Biol Resources, Boumerdes, Algeria

[3] CHU Nafissa Hammoud, Cent Lab, Algiers, Algeria

[4] CHU Nafissa Hammoud, Dept Ophthalmol, Algiers, Algeria

[5] CHU Nafissa Hammoud, Dept Neurol, Algiers, Algeria

来源：

EUROPEAN JOURNAL OF IMMUNOLOGY | 2021年 / 51卷

关键词：

Autoinflammation; cytokines and mediators; immune communication; inflammatory disease; inflammatory molecules; innate immunity;

D O I：

暂无

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

P-0800

引用

页码：240 / 240

页数：1

共 50 条

[31] Metformin inhibits IL-6 signaling by decreasing IL-6R expression on multiple myeloma cells
Ameet K. Mishra
David Dingli
Leukemia, 2019, 33 : 2695 - 2709
[32] Blockade of IL-6 signaling via soluble IL-6R is superior to global IL-6 blockade by antibodies in models of inflammation and septic shock
Rose-John, Stefan
Barkhausen, Tanja
Adam, Nina
Chalaris, Athena
Waetzig, Georg
Scheller, Juergen
CYTOKINE, 2010, 52 (1-2) : 100 - 101
[33] Kynurenine metabolites predict survival in pulmonary arterial hypertension: A role for IL-6/IL-6Rα
Zongye Cai
Siyu Tian
Theo Klein
Ly Tu
Laurie W. Geenen
Thomas Koudstaal
Annemien E. van den Bosch
Yolanda B. de Rijke
Irwin K. M. Reiss
Eric Boersma
Claude van der Ley
Martijn Van Faassen
Ido Kema
Dirk J. Duncker
Karin A. Boomars
Karin Tran-Lundmark
Christophe Guignabert
Daphne Merkus
Scientific Reports, 12
[34] Kynurenine metabolites predict survival in pulmonary arterial hypertension: A role for IL-6/IL-6Rα
Cai, Zongye
Tian, Siyu
Klein, Theo
Tu, Ly
Geenen, Laurie W.
Koudstaal, Thomas
van den Bosch, Annemien E.
de Rijke, Yolanda B.
Reiss, Irwin K. M.
Boersma, Eric
van der Ley, Claude
Van Faassen, Martijn
Kema, Ido
Duncker, Dirk J.
Boomars, Karin A.
Tran-Lundmark, Karin
Guignabert, Christophe
Merkus, Daphne
SCIENTIFIC REPORTS, 2022, 12 (01)
[35] IL-6/IL-6R系统介导靶向治疗白血病策略
崔建武
奚永志
中国实验血液学杂志, 2001, (02) : 184 - 187
[36] Metformin inhibits IL-6 signaling by decreasing IL-6R expression on multiple myeloma cells
Mishra, Ameet K.
Dingli, David
LEUKEMIA, 2019, 33 (11) : 2695 - 2709
[37] IL-4/IL-4R and IL-6/IL-6R genetic variations and gastric cancer risk in the Chinese population
He, Bangshun
Pan, Bei
Pan, Yuqin
Sun, Huiling
Xu, Tao
Qin, Jian
Xu, Xueni
Wang, Shukui
AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2019, 11 (06): : 3698 - 3706
[38] Dual STAT-3 and IL-6R inhibition with stattic and tocilizumab decreases migration, invasion and proliferation of prostate cancer cells by targeting the IL-6/IL-6R/STAT-3 axis
Mendez-Clemente, Anibal
Bravo-Cuellar, Alejandro
Gonzalez-Ochoa, Salvador
Santiago-Mercado, Maria
Palafox-Mariscal, Luis
Jave-Suarez, Luis
Solorzano-Ibarra, Fabiola
Villasenor-Garcia, Maria
Ortiz-Lazareno, Pablo
Hernandez-Flores, Georgina
ONCOLOGY REPORTS, 2022, 48 (02)
[39] Induction of IL-6Rα by ATF3 enhances IL-6 mediated sorafenib and regorafenib resistance in hepatocellular carcinoma
Dai, Zichan
Wang, Xiaohan
Peng, Rangxin
Zhang, Binghui
Han, Qi
Lin, Jie
Wang, Jichuang
Lin, Junjin
Jiang, Mingting
Liu, Hekun
Lee, Tae Ho
Lu, Kun Ping
Zheng, Min
CANCER LETTERS, 2022, 524 : 161 - 171
[40] Interleukin-6 (IL-6) in patients with Behcet's disease
Yamakawa, Y
Sugita, Y
Nagatani, T
Takahashi, S
Yamakawa, T
Tanaka, S
Nakamura, S
Ohno, S
Sekihara, H
Okuda, K
Nakajima, H
JOURNAL OF DERMATOLOGICAL SCIENCE, 1996, 11 (03) : 189 - 195

← 1 2 3 4 5 →